Cargando…

Body Mass Index Influence for the Personalization of the Monoclonal Antibodies Therapy for Psoriasis

Psoriasis is a chronic inflammatory, autoimmune-mediated disease that affects millions of individuals worldwide. Advances in treatment with biological agents represented by monoclonal antibodies, such as TNF-α inhibitors (TNFI), IL-17A and IL-12/23 antagonists have not only benefited from outstandin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anghel, Flavia, Nitusca, Diana, Cristodor, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703749/ https://www.ncbi.nlm.nih.gov/pubmed/34947847 http://dx.doi.org/10.3390/life11121316

Ejemplares similares

Associations between body mass index and severity of psoriasis
por: Sobhan, Mohammadreza, et al.
Publicado: (2017)

Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis
por: Rodríguez-Fernández, Karine, et al.
Publicado: (2022)

Influence of body mass index and weight on etanercept efficacy in patients with psoriasis: A retrospective study
por: Giunta, Alessandro, et al.
Publicado: (2016)

Monoclonal Antibodies in Cancer Therapy
por: Zahavi, David, et al.
Publicado: (2020)

Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study
por: Pirro, Federico, et al.
Publicado: (2021)

Monoclonal Antibody-Based Therapies for Myasthenia Gravis
por: Alabbad, Sawsan, et al.
Publicado: (2020)

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates
por: Albarrán, Víctor, et al.
Publicado: (2022)

Monoclonal Antibody Therapies against Anthrax
por: Chen, Zhaochun, et al.
Publicado: (2011)

Nutritional Therapy in Persons Suffering from Psoriasis
por: Garbicz, Jagoda, et al.
Publicado: (2021)

Body Mass Index and Mortality
por: Yoo, Hye Jin
Publicado: (2017)

Anti CD-6 Monoclonal Antibodies in the Management of Generalised Pustular Psoriasis
por: Kura, Mahendra M., et al.
Publicado: (2022)

Trial watch: Monoclonal antibodies in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Monoclonal Antibody Therapies for High Risk Neuroblastoma
por: Furman, Wayne L
Publicado: (2021)

Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis
por: Mykoniatis, Ioannis, et al.
Publicado: (2022)

Influence of body mass index on the choice of therapy for depression and follow-up care
por: Boudreau, Denise M., et al.
Publicado: (2013)

Body mass index–based predictions and personalized clinical strategies for colorectal cancer in the context of PPPM
por: Gu, Yun-Jia, et al.
Publicado: (2022)

Personality Traits and Body Mass Index in a Korean Population
por: Shim, Unjin, et al.
Publicado: (2014)

Body Mass Index and Melanoma Prognosis
por: Cassano, Nicoletta, et al.
Publicado: (2021)

Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis
por: Pangilinan, Mary Catherine G., et al.
Publicado: (2020)

Monitoring Appropriate Monoclonal Antibodies Prescribing via Administrative Data: An Application to Psoriasis
por: Guidotti, Elisa, et al.
Publicado: (2022)

Genetic Influence on Treatment Response in Psoriasis: New Insights into Personalized Medicine
por: Berna-Rico, Emilio, et al.
Publicado: (2023)

Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies
por: Adams, Rebecca, et al.
Publicado: (2022)

Antibody therapy: Substitution-immunomodulation -monoclonal immunotherapy
por: Mehra, Narinder K.
Publicado: (2019)

Intestinal Microbiota Is Influenced by Gender and Body Mass Index
por: Haro, Carmen, et al.
Publicado: (2016)

Influence of Body Mass Index and Gender on Stigmatization of Obesity
por: Tapking, Christian, et al.
Publicado: (2020)

Mechanistic considerations for the use of monoclonal antibodies for cancer therapy
por: Glassman, Patrick M., et al.
Publicado: (2014)

Novel CD20 monoclonal antibodies for lymphoma therapy
por: Cang, Shundong, et al.
Publicado: (2012)

Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies
por: Senolt, Ladislav
Publicado: (2019)

Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers
por: Hwang, Kyusang, et al.
Publicado: (2021)

Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome
por: Rajabally, Yusuf A.
Publicado: (2022)

Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
por: Struble, Evi B., et al.
Publicado: (2023)

Itolizumab – a humanized anti-CD6 monoclonal antibody with a better side effects profile for the treatment of psoriasis
por: Menon, Roshni, et al.
Publicado: (2015)

Platelet mass index is increased in psoriasis. A possible link between psoriasis and atherosclerosis
por: Unal, Mehmet
Publicado: (2016)

Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study
por: Budu-Aggrey, Ashley, et al.
Publicado: (2019)

Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota
por: Kleinstern, Geffen, et al.
Publicado: (2022)

Monoclonal antibodies for imaging and therapy.
por: Epenetos, A. A., et al.
Publicado: (1989)

Monoclonal antibodies for the therapy of cancer
por: Simpson, Andrew, et al.
Publicado: (2014)

Monoclonal antibody-based therapies
por: Shima, Midori
Publicado: (2018)

Adiponectin in Osteoarthritis: Pathophysiology, Relationship with Obesity and Presumptive Diagnostic Biomarker Potential
por: Ilia, Iosif, et al.
Publicado: (2022)

Influence of Occupational Stress on the Body Mass Index of Hospital Workers: A Systematic Review
por: de Lira, Carlos Rodrigo Nascimento, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8vja92ckmq2sntin10jtuj5dlu